De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Mister Spex Toekomstige groei
Future criteriumcontroles 0/6
Mister Spex is forecast to grow earnings and revenue by 40.7% and 2.2% per annum respectively. EPS is expected to grow by 46.3% per annum. Return on equity is forecast to be -13.1% in 3 years.
Belangrijke informatie
40.7%
Groei van de winst
46.3%
Groei van de winst per aandeel
| Specialty Retail winstgroei | 36.4% |
| Inkomstengroei | 2.2% |
| Toekomstig rendement op eigen vermogen | -13.1% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 29 Aug 2024 |
Recente toekomstige groei-updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 239 | -16 | 2 | 15 | 4 |
| 12/31/2025 | 227 | -25 | -6 | 7 | 4 |
| 12/31/2024 | 220 | -44 | -19 | -8 | 4 |
| 6/30/2024 | 229 | -49 | -12 | -3 | N/A |
| 3/31/2024 | 229 | -49 | 3 | 15 | N/A |
| 12/31/2023 | 228 | -48 | -9 | 6 | N/A |
| 9/30/2023 | 226 | -44 | -18 | -1 | N/A |
| 6/30/2023 | 225 | -44 | -28 | -9 | N/A |
| 3/31/2023 | 220 | -43 | -48 | -29 | N/A |
| 12/31/2022 | 217 | -45 | -41 | -21 | N/A |
| 9/30/2022 | 218 | -32 | -42 | -23 | N/A |
| 6/30/2022 | 209 | -31 | -49 | -31 | N/A |
| 3/31/2022 | 204 | -36 | -47 | -29 | N/A |
| 12/31/2021 | 201 | -32 | -44 | -28 | N/A |
| 9/30/2021 | 195 | -29 | -28 | -14 | N/A |
| 6/30/2021 | 190 | -23 | -8 | 5 | N/A |
| 3/31/2021 | 178 | -11 | -1 | 10 | N/A |
| 12/31/2020 | 168 | -10 | -15 | -2 | N/A |
| 12/31/2019 | 143 | -9 | -7 | 1 | N/A |
| 12/31/2018 | 126 | -11 | -10 | -3 | N/A |
| 12/31/2017 | 107 | -14 | N/A | -11 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: MRX is forecast to remain unprofitable over the next 3 years.
Winst versus markt: MRX is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: MRX is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: MRX's revenue (2.2% per year) is forecast to grow slower than the German market (5.4% per year).
Hoge groei-inkomsten: MRX's revenue (2.2% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: MRX is forecast to be unprofitable in 3 years.